Last reviewed · How we verify
NCT06114680: EarDiTech
Evaluation of the CochSyn Test Prototype to Measure Cochlear Synaptopathy
NA trial testing CochSyn test prototype in Hearing Loss, Sensorineural in 179 participants. Terminated before completion.
23 December 2025
Quick facts
| Lead sponsor | University Ghent |
|---|---|
| Phase | NA |
| Status | Terminated |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | diagnostic |
| Enrollment | 179 |
| Start date | 13 November 2023 |
| Primary completion | 23 December 2025 |
| Estimated completion | 23 December 2025 |
| Sites | 1 location across Belgium |
Drugs / interventions tested
- CochSyn test prototype
- Universal Smart Box (USB)
Conditions studied
- Hearing Loss, Sensorineural — all drugs for Hearing Loss, Sensorineural →
- Cochlear Synaptopathy — all drugs for Cochlear Synaptopathy →
- Cochlear Hearing Loss — all drugs for Cochlear Hearing Loss →
Sponsor
University Ghent
Who can join
Adults 18 to 87, any sex, with Hearing Loss, Sensorineural or Cochlear Synaptopathy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study investigates a newly developed test, The CochSyn test that can quantify cochlear synaptopathy (CS) (a new type of sensorineural hearing loss (SNHL)) earlier than the current golden standard pure-tone audiogram.This newly developed test is based on auditory evoked brain potentials. A hardware prototype (the Cochsyn test prototype) was developed to use the Cochsyn test in clinical practice. Additionally a CS-based sound-processing algorithm (CoNNear) that is designed to improve speech intelligibility in subjects that are identified to have CS, will be investigated in this study.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06114680
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Hearing Loss, Sensorineural
Currently open trials in the same condition.
- NCT06499805 — Barriers and Facilitators to OTC Hearing Aids Success · NA · recruiting
- NCT06560918 — Self-efficacy-based Auditory Rehabilitation With Over-the-Counter Hearing Aids · NA · recruiting
- NCT06882889 — Comparing the Efficacy of Domestic Versus Imported Hearing Aids in ARHL · NA · recruiting
- NCT06664697 — Post-Market Clinical Investigation of the IotaSOFT Insertion System · recruiting
- NCT06268340 — Hearing and Structure Preservation Via ECochG · NA · recruiting
Other University Ghent trials
Trials by the same sponsor.
- NCT07398053 — General Practitioner & Pharmacist Support for Discontinuing Long-term Antidepressants in Clinically Stable Patients · NA · not yet recruiting
- NCT07343258 — Pilot Study on Follow-Up of (Acutely) Suicidal Individuals From the Flemish Suicide Helpline · NA · recruiting
- NCT07091071 — Evaluation of the CochSyn Device in Clinical Practice · NA · completed
- NCT07259408 — Co-creation of Tools for People in Detention With Suicidal Thoughts and/or Behavior · recruiting
- NCT07176156 — Evaluation of the Quality of Chat Conversations With the Suicide Helpline Zelfmoordlijn 1813 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06114680 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Ghent
- Last refreshed: 10 February 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06114680.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing